Search

The article informs about cost effective efforts of Low-Cost Pharma and other pharmaceutical companies. Topics discussed include starting gastroenterology as a subspecialty; commissions from Pharma companies and from equipment manufacturers had been indirectly facilitating the effort of building my department; and commissions from Pharma companies and from equipment manufacturers had been indirectly facilitating my effort of building my department.

The author reflects on the issues concerning high prices of medicines in India. He cites the result of a study which determines the factors that caused the crisis in the price of drugs and how to address the issue. The author also asserts how the outcry for cheaper medicines has pushed pharmaceutical companies to partially or entirely outsource basic chemicals to unreliable source, relegating the quality of products to the lowest priority.

The article offers information on a gastroenterology conference which involved panel discussion with four hepatologists as co-panellists and other members. Topics discussed include use of generic drugs for treatment of hepatitis C virus (HCV) in India; information regarding treatment of the patients with HCV using sofosbuvir and daclatasvir; and need for organizing informative continuing medical education (CME).